Most Recent Additions*
The Creditors' Bargain Reconstituted: Comments on Barry Adler's The Creditors' Bargain Revisited
Edward Janger
When Women’s Silence Is Reasonable: Reforming the Faragher/Ellerth Defense in the #MeToo Era
Elizabeth C. Potter
Pharmaceutical Philanthropy or Resisting Regulations?: Why Pharmaceutical Donations Do Not Violate the Anti-Kickback Statute
Tino Illiparambil
Bargaining Over Biometrics: How Player Unions Should Protect Athletes in the Age of Wearable Technology
Skyler R. Berman
Out of Options: The Obstructions Hindering Victims of Non-State Actor Violence Under Current Asylum Law
Kenneth D. Law Jr.
Fraying the Knot: Marital Property, Probate, and Practical Problems with Tribal Marriage Bans
Suzianne D. Painter-Thorne
The Common Law of Cyber Trespass
Michael J. O'Connor
Asymmetries in Immigration Protection
Sabrineh Ardalan
An Intellectual History of Mass Incarceration
Alice Ristroph
The Place of the People in Criminal Procedure
Jocelyn Simonson
Partnership-Related Relatedness: Measuring Partners' Capital Interests and Profits Interests
Bradley T. Borden
Basic and Non-Basic Tax Tips for Leasing Lawyers
Bradley T. Borden
Investing in a Qualified Opportunity Fund: A Viable Alternative to a Section 1031 Drop-Swap Cash-out
Bradley T. Borden
Negative Liberty Meets Positive Social Change
Anita Bernstein
(Almost) No Bad Drugs: Near-Total Products Liability Immunity for Pharmaceuticals Explained
Anita Bernstein
*Updated as of 05/29/20.